OTC:ACBM | Free Cash Flow | ACRO BIOMEDICAL CO., LTD.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$49,821.00
2025-12-31-$25,377.00
2025-03-31-$22,531.00
2024-12-31-$10,515.00
2024-03-31-$13,513.00
2023-12-31-$12,613.00
2023-03-31-$5,566.00
2022-12-31-$10,568.00
2022-03-31$262,132.00
2021-12-31-$60,506.00
2021-03-31-$8,380.00
2020-12-31-$37,014.00
2020-03-31-$26,014.00
2019-12-31$34,928.00
2019-09-30$42,874.00
2019-03-31-$52,335.00
2018-12-31$174,329.00
2018-09-30-$4,167.00
2017-12-31-$33,260.00
2017-09-30-$416,175.00
2016-12-31-$142.00
2016-09-30-$9,608.00
2015-12-31-$11,368.00
2015-09-30-$1,518.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$196,302.00
2024-12-31-$36,692.00
2023-12-31-$15,446.00
2022-12-31-$147,481.00
2021-12-31$299,335.00
2020-12-31-$199,460.00
2019-12-31-$59,709.00
2019-09-30$79,692.00
2018-09-30-$140,419.00
2017-09-30-$463,344.00
2016-09-30-$34,742.00
2015-09-30-$48,850.00